Kidney Res Clin Pract.
2018 Sep;37(3):183-184. 10.23876/j.krcp.2018.37.3.183.
Mineralocorticoid receptor blockade for renoprotection
- Affiliations
-
- 1Division of Nephrology, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea. cdragn@unitel.co.kr
- KMID: 2447157
- DOI: http://doi.org/10.23876/j.krcp.2018.37.3.183
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Aldosterone Receptor Blockade Prevents Inflammatory Reaction on Type 2 Diabetic Nephropathy
- Efficacy of low-dose spironolactone on top of angiotensin receptor blockade in patients with glomerulonephritis
- Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors
- Medical Management of Patients With Heart Failure and Reduced Ejection Fraction
- A case of pseudohypoaldosteronism type 1 with a mutation in the mineralocorticoid receptor gene
